Zenalpha

RSS

medetomidine hydrochloride / vatinoxan hydrochloride

Authorised
This medicine is authorised for use in the European Union.

Overview

Zenalpha is a medicine used to sedate (calm down) dogs during non-invasive, non-painful or mildly painful veterinary procedures lasting less than 30 minutes that require the animal to be restrained or sedated and made less sensitive to pain.

Zenalpha contains the active substances medetomidine and vatinoxan.

This EPAR was last updated on 15/03/2022

Authorisation details

Product details
Name
Zenalpha
Agency product number
EMEA/V/C/005465
Active substance
  • medetomidine hydrochloride
  • vatinoxan hydrochloride
International non-proprietary name (INN) or common name
  • medetomidine hydrochloride
  • vatinoxan hydrochloride
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QN05CM99
Publication details
Marketing-authorisation holder
Vetcare Oy
Date of issue of marketing authorisation valid throughout the European Union
15/12/2021
Contact address

P.O.Box 99
24101 Salo
Finland

Product information

Zenalpha - EMEA/V/C/005465 -

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Psycholeptics, hypnotics and sedatives

Therapeutic indication

To provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.

Assessment history

How useful was this page?

Add your rating